Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil.
Hata
Takaki
T
Department of Cardiovascular Medicine, Hiroshima University, Hiroshima, Japan.
Goto
Chikara
C
Soga
Junko
J
Hidaka
Takayuki
T
Fujii
Yuichi
Y
Idei
Naomi
N
Fujimura
Noritaka
N
Maruhashi
Tatsuya
T
Mikami
Shinsuke
S
Kihara
Yasuki
Y
Chayama
Kazuaki
K
Noma
Kensuke
K
Liao
James K
JK
Higashi
Yukihito
Y
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000328:Adult; D000368:Aged; D050197:Atherosclerosis / Q000378:metabolism*; D001783:Blood Flow Velocity; D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009218:Myosins / Q000737:chemistry*; D010744:Phosphoric Monoester Hydrolases / Q000737:chemistry; D014665:Vasodilator Agents / Q000494:pharmacology; D054460:rho-Associated Kinases / Q000378:metabolism*
D014665:Vasodilator Agents; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D054460:rho-Associated Kinases; D010744:Phosphoric Monoester Hydrolases; D009218:Myosins; C049347:fasudil